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Listeria monocytogenes (LM) vectors have shown much promise in delivery of viral an
tumor antigens for the development of vaccines. L. ivanovii (LI) is a closely relate
bacterium with a similar intracellular life cycle that may offer advantages over L
because it is not a human pathogen, but can infect other animal species. Recen
studies show that recombinant LI expressing Mycobacterium tuberculosis antigens i
effective in inducing protective immunity in mouse models, demonstrating the potentia
of LI as a live vaccine vector. However, a key barrier in the development of LI into
live vaccine vector is that its pathogenic and immunogenic characteristics have yet t
be fully understood. Therefore, in this research, C57BL/6J mice were inoculated wit
LM or LI intravenously or intranasally, and bacterial loads, histopathologic changes
and cytokine production were determined at indicated days post inoculation. Result
showed that after intravenous infection with LM or LI, bacteria were found proliferatin
in the liver, spleen, and lung. However, LI could only reach a heavy burden in the liver an
its ability to multiply and to resist host immunity seemed limited in the spleen and lung
After intranasal inoculation with LI, bacteria were mainly localized in the lung and faile
to infect liver or spleen, while LM could. In organs with heavy LI burden, lesions wer
isolated, localized and densely packed, compared to lesions caused by LM, which wer
invasive. In the liver of intravenously inoculated mice and lung of intranasally inoculat
mice, LI was able to elicit comparable cytokine production with LM and cause les
severe histopathologic damages, and thus could be considered as a vector for treatin
or preventing hepatic or pulmonary diseases.
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INTRODUCTION
Listeria monocytogenes (LM) is a Gram-positive, food-borne pathogen responsible for human
and animal listeriosis, characterized by severe gastroenteritis, central nervous system infections,
and mother-to-child infections, with an overall mortality rate of 30% (Roberts and Wiedmann,
2003). LM is capable of multiplying in the cytoplasm of phagocytic and non-phagocytic cells and
directly infecting adjacent cells, guaranteeing efficient antigen processing and presentation, which
thereby enables it to elicit robust innate and antigen-specific cellular immunity (Stavru et al., 2011).
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Consequently, LM is now being used as both a model to
investigate host immune responses as well as a vaccine vector
for T cell immunity (Singh and Wallecha, 2011; Stavru et al.,
2011). Research into LM-based vaccines has made great progress
in the last 20 years. Diverse antigen genes, such as genes of
tumor related antigens and virus antigenic genes, have been
genetically recombined into LM or attenuated strains, exhibiting
desirable results in vivo, including tumor shrinkage, activated T
cell immunity, and survival following higher challenging doses in
mice (Mata et al., 2001; Brockstedt et al., 2004; Wood et al., 2011).
So far, five LM-based vaccine candidates have been tested and are
in various phases of clinical trials (Le et al., 2012).
In comparison, L. ivanovii (LI), the other pathogenic
bacteria in the Listeria genus, is strictly limited to ruminant
infection, except for extremely rare cases of infection in
immunocompromised people (Dominguez-Bernal et al., 2006;
Snapir et al., 2006; Guillet et al., 2010). Despite its different host
tropism, LI is the bacterial species most similar to LM, sharing
similar mechanisms for phagosome escape, intracellular mobility,
reproduction, and cell-to-cell spreading (Vazquez-Boland et al.,
2001b; Dominguez-Bernal et al., 2006). Therefore, LI could
potentially be a promising vaccine vector even better than LM
considering its lower pathogenicity in humans. Unfortunately,
no research on LI-based vaccines has been reported until
very recently, when two recombinant LI strains expressing
Mycobacterium tuberculosis ESAT-6 or Ag85C protein were
constructed and tested in vivo as tuberculosis vaccine candidates
(Lin et al., 2015). Specific gamma interferon (IFN-γ) secretion
of activated CD8 T cells was observed, which indicated the
possibility of using LI as vaccine vector. However, the pathogenic
and immunogenic features of LI and differences to LM remain
poorly understood. Therefore, in order to correctly utilize LI as
a novel live bacteria vaccine vector, it is important to conduct
comprehensive studies such as the one detailed here.
In this study, C57BL/6J mice were inoculated intravenously
(i.v.) or intranasally (i.n.), two effective routes of administration
already established in C57BL/6J mice (Mayuko et al., 2002). Then,
bacterial loads, histopathology and cytokine secretion kinetics
along with infection course were systematically studied and
compared between LM and LI infected mice.
MATERIALS AND METHODS
Animals
Female C57BL/6J mice were purchased from Beijing HFK
Bioscience Company (Beijing, China). Mice aged 6–8 weeks were
used in this study. All mice were maintained under specific-
pathogen-free conditions throughout the experiments at the
Animal Center of School of Public Health at Sichuan University.
Mouse experiments were performed according to the guidelines
of the Animal Care and Use Committee of Sichuan University.
Bacteria and Inoculum Preparation
LM 10403s strain and LI PAM55 strain were used in this study.
All bacteria were stored in brain-heart infusion (BHI) broth
containing 50% glycerol at −80◦C. Bacteria were recovered in
BHI broth from −80◦C storage, and cultured in fresh BHI broth
at 37◦C and 200 rpm to mid-logarithmic phase (OD600≈0.4),
then centrifuged at 4◦C at 12000 g for 2 min, washed with
normal saline, and then resuspended in normal saline. Titers
of live bacteria were adjusted according to OD600 vs. bacteria
concentration curves obtained in our earlier work (data not
shown). Actual numbers of colony forming units (CFUs) of
bacteria were verified by plating diluted inoculums on BHI agar
plates.
Mouse Infection and Sacrifice
One hundred and sixty-two mice were randomly distributed into
four infection groups (36 mice in each) and one naive group
(18 mice). Two infection groups of mice were i.v. infected with
5 × 104 CFU LM or 5 × 105 CFU LI in a volume of 100 µl. The
other two infection groups of mice were anesthetized by diethyl
ether, and then i.n. inoculated with 5 × 105 CFU LM or 5 × 107
CFU LI in 25 µl of normal saline. All infection doses were 10-fold
lower than the 50% lethal doses determined previously (data not
shown). Naive group of mice were untreated. At 1, 2, 3, 5, and 8
each day(s) post inoculation (dpi), six mice in each i.v. infection
group were sacrificed for analysis of bacterial loads and cytokine
titers in organs. At 1, 3, 5, 8, and 11 each dpi, six mice in each i.n.
infection group were sacrificed for the same analysis. At 4 and
6 each dpi, six mice in naive group were sacrificed for the same
analysis. Additionally, six mice in each group were sacrificed for
histopathologic analysis at 3 dpi (i.v. group), 5 dpi (i.n. group), or
4 dpi (naive group).
Determination of Bacteria Load in
Organs from Listeria-Infected Mice
Liver, spleen, and lung were removed aseptically. Around
0.05 g tissue (the smallest lobe of liver, half spleen and one
lobe of lung) was cut off and stored in liquid nitrogen for
cytokine determinations. The rest of the tissue was weighed
and homogenized in sterilized and pre-cooled phosphate buffer
solution (PBS) containing 0.1% Triton-X100. Serial dilutions of
homogenates were plated on BHI agar plates and cultured at
37◦C. Colonies were counted after 24 h for LM or after 48 h
for LI.
Histopathologic Analysis of Tissue from
Listeria-Infected Mice
Liver, spleen, and lung were fixed in 10% buffered formalin,
dehydrated and embedded in paraffin. Sections of 5 µm
were cut, stained with hematoxylin-eosin and examined under
100×magnification.
Preparation of Organ Extracts and
Luminex Measurements of Cytokines
Frozen tissue was removed from liquid nitrogen, and ground
in a cold mortar. Lysis buffer (50 mmol/L Tris-HCl pH7.4,
150 mmol/L NaCl, 1mmol/L EDTA, 1% Triton X-100, 1mmol/L
phenylmethanesulfonyl fluoride, 5 µg/ml aprotinin, 5 µg/ml
leupeptin) 100 µl, was added to lyse the tissue. Samples
were incubated on ice for 10 min and vortexed for 2 min,
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FIGURE 1 | Weight changing percentages after intravenous or intranasal inoculation with LM and LI. Mice were i.v. inoculated with 5 × 104 CFU LM or
5 × 105 CFU LI (A), or i.n. inoculated with 5 × 105 CFU LM or 5 × 107 CFU LI (B). Weight changing percentages were calculated and compared between LM (#)
and LI ( ) at the same time point by the method of t test (∗P < 0.05). Each point represents mean ± standard error of the mean of six mice per group.
repeating twice. Samples were then centrifuged at 4◦C and
16000 g for 10 min, and the supernatant was collected.
Total protein concentration of each sample was measured
using BCA Protein Assay kit (Beyotime, Shanghai, China)
and was diluted to 10 mg/ml with PBS. All samples were
stored at −80◦C. Cytokine measurements were performed with
a Luminex R©100TM instrument using a ProcartaPlex Mouse
Essential Th1/Th2 Cytokines Panel (eBioscience, San Diego, CA,
USA). All procedures of cytokine determination were based on
the manufacturer’s instructions.
Statistical Analysis
Differences of daily weight between LM and LI infection mouse
models were analyzed by t-test. Bacterial loads and cytokine titers
in organs were compared by using the Mann–Whitney U non-
parametric test. In all experiments, P < 0.05 was considered
significant.
RESULTS
Kinetics of LM and LI Growth in Organs
from Intravenous and Intranasal
Infection Models
Four groups were either inoculated with 5 × 104 CFU LM
(i.v.), 5 × 105 CFU LI (i.v.), 5 × 105 CFU LM (i.n.), or
5 × 107 CFU LI (i.n.). Each dose was 10-fold lower than the
50% lethal dose determined previously (data not shown). As
an additional parameter of measurement during the course of
infection, percentages of weight change after infection were taken
daily (Figure 1). In intravenous infection model, mice infected
either Listeria species started to lose weight at 1 dpi and then
recovered gradually (Figure 1A). However, mice infected with
LM reached maximum weight loss (6% of original weight) at 3
and 4 dpi and returned to original weight at 7 dpi, while mice
infected with LI showed only slight weight loss (Figure 1A).
After intranasal infection, mice infected with either LM or LI
started to lose weight over 1 to 4 dpi and recovered to original
weight at 9 dpi, but more weight loss was induced by LI infection
(Figure 1B). The maximum weight loss for mice intranasally
infected with LM was 8% of original weight while that for mice
infected with LI was 13% of original weight (Figure 1B).
Bacterial loads in the liver, spleen, and lung were determined
at indicated time points. In mice intravenously inoculated with
5 × 104 CFU LM, the bacterial load in the liver, though
significantly less than that of LI at 1 dpi, kept increasing and
reached maximum load of 4 × 104 CFU/g at 3 dpi (Figure 2A).
By contrast, in mice intravenously inoculated with 5 × 105 CFU
LI, about 88% of the bacteria invaded liver, causing the bacteria
load in liver to reach 4× 105 CFU per g then decreased gradually
(Figure 2A). However, in the spleen after intravenous infection,
LM showed notable and prolonged growth (Figure 2C). In mice
intravenously inoculated with 5 × 105 CFU LI, the maximum
load was 5 × 103 CFU per g spleen, while for mice inoculated
with a smaller dose of LM, the maximum value was 3 × 106
CFU per g spleen (Figure 2C). Additionally, the load of LI in the
spleen decreased below the detection limit after 3 dpi, but LM
were still detectable at 8 dpi, showing that LI was cleared rapidly
in host spleen (Figure 2C). In the lung after i.v. infection, though
both LM and LI could reach a maximum load around 3 × 104
CFU per g lung, the former could resist host immunity and
persist in the lung for over 5 days while the latter only persisted
for 3 days, again showing its weak ability to maintain infection
(Figure 2E).
In the liver from intranasal infection model, LM proliferated
after 1 dpi, reached a peak value of 4 × 103 CFU per g liver
at 5 dpi, and was undetectable at 8 dpi. In stark contrast, LI
were hardly detectable for the duration of the experiment even
though the dose was 100-fold higher than LM (Figure 2B).
The same situation was also observed in the spleen, where
levels of LM peaked at 3 dpi (105 CFU per g spleen), while
LI remained at undetectable level for the duration of the entire
experiment (Figure 2D). However, a difference was observed
in the lung following intranasal inoculation. The bacterial load
of LM increased after 1 dpi, peaked at 5 dpi, and gradually
declined to undetectable levels at 11 dpi, presenting a distinct
proliferative process (Figure 2F). In contrast, the load of LI
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FIGURE 2 | Kinetics of LM and LI loads in liver, spleen, and lung from intravenous and intranasal infection models. Mice were i.v. inoculated with 5 × 104
CFU LM or 5 × 105 CFU LI, and bacterial loads in the liver (A), spleen (C), and lung (E) were determined. Mice were i.n. inoculated with 5 × 105 CFU LM or 5 × 107
CFU LI, and bacterial loads in the liver (B), spleen (D), and lung (F) were determined. The number of LM (#) and LI ( ) in certain organ at indicated time points were
compared by the method of the Mann–Whitney U non-parametric test (∗P < 0.05) at the same time point. Each point represents the mean ± standard error of the
mean for a group of six mice. The dotted lines represent the detection limits in each experiment.
maintained around 105 CFU per g lung for the first 5 days and
sharply dropped below the detection limit at 8 dpi (Figure 2F).
Though the maximum load of LI (4 × 105 CFU per g lung)
in the lung were slightly higher than that of LM (6 × 104
CFU per g lung), the inoculation dose of LI was 100-fold
higher, indicating that the LI could not resist host immunity
and multiply as well as LM could in the lung. Taken together,
after intranasal inoculation LI was mainly localized in the
lung and could barely invade liver or spleen, while LM could
multiply in these three organs, again demonstrating LI is less
pathogenic.
Histopathologic Analysis of Organs
Infected with LM or LI from Intravenous
and Intranasal Infection Models
To study and compare tissue damage in host organs caused by
LM or LI, mice that were intravenously infected were sacrificed
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at 3 dpi, mice that were intranasally infected were sacrificed
at 5 dpi, and naive mice were sacrificed at 4 dpi. Histologic
sections of liver, spleen, and lung samples were then made and
analyzed (Figure 3). In the livers from intravenous infection
model, lesions caused by LM were numerous and mainly located
near vessels (Figure 3D), while lesions caused by LI were fewer
but larger in size, featuring layers of necrotic hepatocytes and
lymphocytes surrounding each other (Figure 3G). In the spleen
from intravenous infection model, however, histopathology
was consistent with bacteria load. LM infection led to severe
necrosis which expanded to entirely efface the normal splenic
architecture (Figure 3E), while no substantial changes were
observed in LI infected spleens (Figure 3H). In the lung after i.v.
infection, collapsed alveoli accompanied with lymphocytes were
observed, along with more numerous and severe lesions for LM-
infected mice (Figure 3F) than for LI-infected mice (Figure 3I).
Compared to the intravenous infection model, both LM and
LI inoculated intranasally presented smaller and fewer hepatic
lesions and hardly observed splenic necrosis (Figures 3J,K,M,N).
However, tissue damage of the lungs was severe and differed
between mice infected with the two bacterial strains. Following
intranasal infection with LM, pulmonary necrosis along with
inflammatory infiltration expanded to a large area (Figure 3L).
In contrast, lung lesions caused by LI were isolated and
densely packed in a pattern similar to LI intravenously infected
liver, where the bacterial burden was also heavy (Figure 3O).
Histopathological results were consistent with bacterial loads, in
that severe histopathologic changes were observed in tissues with
high bacterial loads. However, lesions caused by LI were found
isolated and densely packed which indicated the ability of LI to
expand infection foci might be limited.
Kinetics of Cytokine Production in
Organs Infected with LM or LI from
Intravenous and Intranasal Infection
Models
To investigate and compare inflammatory responses associated
with LM and LI infection via intravenous (Figure 4) or intranasal
(Figure 5) infection route, four groups of mice were inoculated
accordingly. One group of mice was left uninfected as a naive
control group. At indicated time points, Luminex beads assay was
performed to determine cytokine titers in the liver, spleen, and
lung, including tumor necrosis factor alpha (TNF-α), interleukin-
12 (IL-12), interleukin-6 (IL-6), interleukin-4 (IL-4), and IFN-γ.
The kinetics of cytokine production in mice infected with LM or
LI differed by organs and inoculation routes.
Intravenous Infection Model
Liver
In the liver after intravenous injection, cytokines titers in LI
inoculated mice were generally at comparable levels to titers in
LM inoculated mice (Figure 4). TNF-α and IL-12 titers showed
no substantial differences between mice infected with LM and
LI at 1, 2, 3, and 5 dpi, except at 8 dpi (Figures 4A,D). IL-
6 production was increased and reached a peak titer at 2 dpi
after both Listeria infections and no difference of daily IL-
6 production was found between LM and LI-infected mice
(Figure 4G). IFN-γ titers in the liver were notably increased at
2 dpi in both LM and LI infected mice, but IFN-γ titer in LI
infected mice decreased after 3 dpi while that in LM infected mice
remain at a high level (Figure 4J). IL-4, an antagonistic factor
in anti-listeriosis response, showed no differences between mice
inoculated with the two Listeria strains within the 5 experimental
days (Figure 4M).
Spleen
In the spleen following intravenous infection, however, cytokines
production induced by LI were at significantly lower levels when
compared with LM. For example, TNF-α titer for LM infected
mice was significantly elevated (32.0 and 21.3 pg/mg total lysate
protein) at 2 and 3 dpi, respectively, while the titer for LI for
the same dpis were around 3.0 pg/mg total lysate protein, not
significantly higher than it of naive mice (Figure 4B). The titers
of IL-12 were increased after infection with either Listeria species,
but the titer of LM infected mice was much higher (Figure 4E).
Moreover, levels of both IL-6 and IFN-γ induced by LI were lower
than those induced by LM at each experimental day, but they
were still higher than those of naive mice and reached peak values
of 4.5 pg/mg total lysate protein IL-6 and 17.3 pg/mg total lysate
protein IFN-γ at 2 dpi (Figures 4H,K). IL-4 titer in the spleen
kept declining during the course of LM infection, whereas titers
for LI infection declined first and then returned to the level of
naive control group since 5 dpi (Figure 4N).
Lung
No substantial differences in TNF-α, IL-12, and IL-4 secretion
in the lung were found between LM and LI infected mice, but
pulmonary IL-6 and IFN-γ induced by LM were significantly
higher. No difference in titer of TNF-α was observed between the
two bacteria in intravenously infected mice until 8 dpi, when a
high titer of TNF-α (2.8 pg/mg total lysate protein) was found
in the LM-infected mice (Figure 4C). Similarly, the difference
of IL-12 titer between LM and LI occurred only at 8 dpi with
IL-12 titer as low as 0.03 pg/mg total lysate protein in LI-infected
mice (Figure 4F). IL-6 production in the lung after LM infection
showed an obvious increase up to 9.5 pg/mg total lysate protein at
3 dpi, while the production after LI infection was barely increased
(Figure 4I). Titers of pulmonary IFN-γ in LM infected mice was
at least five times higher than that in LI infected mice (Figure 4L).
No differences were found in IL-4 secretion in the two Listeria
infected mice (Figure 4O).
Intranasal Infection Model
Liver
Cytokine titers in the liver and spleen were generally lower in
the intranasal infection model than in the intravenous infection
model, however, cytokine production in the lung were higher
after i.n. infection than after i.v. infection, a finding consistent
with bacterial burdens (Figure 5). In the liver from intranasal
infection model, production of cytokines, except IFN-γ, were not
notably promoted after infection with either Listeria. Kinetics of
TNF-α, IL-12, and IL-4 induced by the two bacteria were the same
(Figures 5A,D,M). IL-6 titer only differed at 1 dpi with 1.8 pg/mg
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FIGURE 3 | Histopathologic analysis of liver, spleen, and lung from LM and LI intravenous and intranasal infection models. Mice were, respectively,
inoculated with 5 × 104 CFU LM (i.v.), 5 × 105 CFU LI (i.v.), 5 × 105 CFU LM (i.n.) or 5 × 107 CFU LI, along with a group of naive mice. I.v. infected mice were
sacrificed at 3 dpi, i.n. infected mice were sacrificed at 5 dpi, and naive mice were sacrificed at 4 dpi. Histologic sections of liver, spleen, and lung were made and
stained with hematoxylin-eosin. Liver and lung sections were observed under a 40× microscope and spleen sections were observed under a 10× microscope. The
images presented are representatives of changes seen in naïve mice (A–C), LM i.v. (D–F), LI i.v. (G–I), LM i.n. (J–L), and LI i.n. (M–O).
total lysate protein for the LM infected mice and 4.1 pg/mg
total lysate protein for the LI infected mice (Figure 5G). IFN-
γ production, however, were significantly different between LM
and LI i.n. infected mice. Hepatic IFN-γ in LI inoculated mice
slightly changed within the range of naïve mice, while LM
induced IFN-γ highly secreted in the liver, 16.5 pg/mg total lysate
protein at 3 dpi and 14.5 pg/mg total lysate protein at 11 dpi
(Figure 5J).
Spleen
In the spleen from intranasal infection model, cytokine levels in
LM infected mice were notably increased at 3 dpi while changes
of cytokine levels in LI-infected mice were less significant. Titers
of TNF-α and IL-12 were obviously increased to 10.1 pg/mg total
lysate protein and 0.2 pg/mg total lysate protein at the third day
after infection with LM while production of TNF-α and IL-12
barely changed after infection with LI (Figures 5B,E). The peak
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FIGURE 4 | Kinetics of cytokine production in organs from LM and LI intravenous infection models. Mice were, respectively, inoculated with 5 × 104 CFU
LM (white bar) or 5 × 105 CFU LI (black bar), and one group of naive mice were set (solid line represents average value and the dotted line represents average value
plus/minus standard deviation). Titers of TNF-α (A–C), IL-12 (D–F), IL-6 (G–I), IFN-γ (J–L), and IL-4 (M–O) in the liver, spleen, and lung were determined at 1, 2, 3,
5, and 8 dpi for Listeria infected mice or at 4 dpi for naive mice. The differences of titers at each test day were compared between LM and LI by the method of the
Mann–Whitney U non-parametric test (∗P < 0.05). Each bar represents the mean ± standard error of the mean for a group of six mice.
for IL-6 secretion occurred at 1 dpi with a titer of 22.5 pg/mg
total lysate protein in LI infected mice, but in LM infected mice,
the IL-6 peak occurred at 3 dpi with a titer of 29.3 pg/mg total
lysate protein (Figure 5H). IFN-γ production was significantly
higher following LM intranasal infection at 3, 5, 8, and 11 dpi
(Figure 5K). Titers of IL-4 decreased after infection with both
Listeria but it recovered earlier in LI infected mice (Figure 5N).
Lung
In the lung after intranasal infection, where the bacteria were
mainly focused, cytokine titers were generally higher than those
in the lung from the intravenous infection model, but fewer
differences were found between mice infected with LM and
LI. TNF-α, IL-6, and IL-4 production separately shared similar
trends and levels in mice infected with LM or LI (Figures 5C,I,O).
The peak of IL-12 was at 1 dpi in LI infected mice but occurred
at 3 dpi in LM infected mice (Figure 5F). The titer of IFN-γ was
higher in LM intranasally infected lung at 3, 5, 8, and 11 dpi, and
the biggest difference presented at 5 dpi with 72.1 pg/mg total
lysate protein in LM infected mice but only 9.4 pg/mg total lysate
protein in LI infected mice (Figure 5L). However, the difference
was not statistically significant.
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FIGURE 5 | Kinetics of cytokines production in organs from LM and LI intranasal infection models. Mice were, respectively, inoculated with 5 × 105 CFU
LM (white bar) or 5 × 107 CFU LI (black bar), and one group of naive mice were set (solid line represents average value and the dotted line represents average value
plus/minus standard deviation). Titers of TNF-α (A–C), IL-12 (D–F), IL-6 (G–I), IFN-γ (J–L), and IL-4 (M–O) in the liver, spleen, and lung were determined at 1, 3, 5,
8, and 11 dpi for Listeria infected mice or at 6 dpi for naive mice. The differences of titers at each test day were compared between LM and LI by the method of the
Mann–Whitney U non-parametric test (∗P < 0.05). Each bar represents the mean ± standard error of the mean for a group of six mice.
DISCUSSION
In this study pathogenic and immunologic outcomes of LI
intravenous or intranasal infections in C57BL/6J mice were
investigated in comparison with LM. In intravenous infection
model, bacteria were delivered into the bloodstream and directly
distributed to organs. In the spleen and lung, LI showed reduced
pathogenicity compared with LM, as demonstrated by low and
transient bacterial loads and minor histopathologic changes.
In the liver, however, LI could rapidly reach a high burden,
caused notable pathogenic damages and then cleared by host
gradually. It indicated that LI in blood were mainly distributed
to liver, which, to our knowledge, is related to a protein called
Internalin B (InlB). In LM, InlB is found to trigger the entry
of LM into hepatocytes by interacting with a hepatocyte growth
factor receptor and two other cellular components (Bierne and
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Cossart, 2002). LM mutant lacking the gene encoding InlB (inlB)
displays a marked decrease in its capability to proliferate within
mouse hepatocytes in vivo and in vitro (Gregory et al., 1997).
The existence of InlB for LI has been proved by gene sequencing.
Two genes named i-inlB1 and i-inlB2 were found to be genetically
similar to inlB of LM, and were thought to code for an InlB
ortholog in LI (Dominguez-Bernal et al., 2006). Comparing
their amino acid sequences, both i-InlB1 and i-InlB2 share a
similar architecture with InlB for the internalin domain and
bacterial-surface anchoring domain, indicating that i-InlB1 and
i-InlB2 may mediate the interaction between LI and hepatocytes.
However, detailed differences in structure and function in vivo
among these three internalins and how i-InlB1 and i-InlB2
interact hepatocytes are still wanted.
Another finding in intravenous infection model is that LI
failed to keep multiplying as long as LM did and were cleared
by host more rapidly, especially in the spleen and lung. After
analyzing typical histopathologic changes of LI (Figures 3G,O),
it was found that LI infection foci was isolated and densely
packed while LM infection foci was invasive, indicating that,
compared with LM, the abilities of LI to multiply intracellularly
and/or to invade neighboring cells are limited. It has been proved
that LI is not as capable of multiplying in splenic cells as LM
in vitro (Kimoto et al., 2003). This flaw could be related to
LI’s poor ability to lyze phagosome, since LM mutant unable to
effectively disrupt phagosome and escape into cytoplasma is soon
cleared (Gaillard et al., 1986). Phagosome lysis is initiated by
three LM virulence determinants: listeriolysin O (LLO) and two
phospholipases (PlcA and PlcB; Vazquez-Boland et al., 2001b).
These three molecules are also found in LI. Ivanolysin O (ILO)
is the homolog of LLO in LI. A LM mutant expressing ILO
instead of its own LLO failed to proliferate in the spleen, inducing
a high-level of IFN-γ, as well as generating robust protective
immunity (Frehel et al., 2003; Hideki et al., 2007), which indicates
the weak ILO may be responsible for deficient intracellular
multiplication of LI. PlcA and PlcB of LI are only verified
genetically, and no details about their structure and function
are available (Vazquez-Boland et al., 2001a). After escaping from
the ruptured phagosome, LM replicates in the cytoplasm and
expresses the surface molecule ActA which provides the bacteria
with actin-based motility and propels it through membrane
protrusions into neighboring cells to expend infection to a large
area (Vazquez-Boland et al., 2001b). In LI, the ActA-like protein
is called i-ActA and can restore mobility of LM actA deletion
mutant strain in vitro (Gouin et al., 1995). However, detailed
differences between i-ActA and ActA in the process of cell-to-
cell infection remain unclear. So far, major virulence factors
of LM has been genetically recognized in LI (Vazquez-Boland
et al., 2001a). Similarities in genes between these homologs imply
similar functions, but it is the differences that help to explain
different behavior in vivo between LM and LI. More information
is needed to make reliable conclusions.
In this research, immunologic features of LI in different organs
after different inoculation were also conducted in comparison
with LM. Five cytokines were adopted to reflect different aspects
of host anti-Listeria immune response, due to sufficient data of
host immunity to LM. TNF-α, IL-6, and IL-12 are secreted by
LM infected macrophages to recruit and activate neutrophils and
NK cells, which are both capable of killing infected cells (Harty
et al., 1996; Mocci et al., 1997). IFN-γ is mainly secreted by
activated NK cells to enhance bactericidal actions inside infected
macrophages and promote expression of signal molecules on
surface to further amplify immune stimulation (Pamer, 2004).
Apart from innate immune response, T cell-mediated immune
response also takes part in host immunity to first time infection
of LM. IL-6 and IL-12 play a role in promoting Th0 cells to
develop into Th1 cells, while IL-4 suppresses the development
(Kaufman et al., 1997; Mocci et al., 1997). In this research, though
the magnitude and duration of each cytokine differed between the
two Listeria, the trends along with infection are same, which are
increase of TNF-α, IL-6, IL-12, and IFN-γ and decrease of IL-
4. The same secretion trend of cytokines implies host immune
response to LI is similar with it to LM. However, in most cases,
cytokine response to LM was stronger than that to LI, which was
likely due to different behavior in tissues between LM and LI. In
infected tissue, LM increased in number exponentially while LI
was either cleared or not growing, and thus LI did not induce
cytokine response as robust as LM did. This phenomenon, on
the one hand, proves that LI is less virulent, and on the other
hand indicates that LI, as a vaccine vector, needs optimization for
stronger immunogenicity.
Nevertheless, cytokine secretion induced by LI infection was
at comparable level of LM infectoin in these two situations:
in the liver from i.v. inoculated mice and in the lung from
i.n. inocualted mice. Titers of TNF-α, IL-6, IL-12, and IL-4
after infection changed at same level between LI and LM
infections. IFN-γ in the liver after i.v. infection dropped earlier
in LI infected mice than LM infected mice because LI could
be cleared rapidly. IFN-γ in the lung after i.n. infection
seemed higher in LM infected mice at 3 and 5 dpi, but the
difference was not statistically significant due to individual
differences. In general, LI could mainly infect mouse liver
after i.v. inoculation and specifically infect mouse lung after
i.n. inoculation. In these two situations, LI could induce
immune response not significantly weaker than LM, cause less
sever tissue damages and could be controlled by host more
easily. Therefore, speculation is that LI, after being genetically
improved for better immunogenicity, could be used as vaccine
vector specific for hepatic or pulmonary disease, especially for
immunocompromised people.
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